Human Gene CAPN10 (uc002vzk.2)
  Description: Homo sapiens calpain 10 (CAPN10), transcript variant 1, mRNA.
RefSeq Summary (NM_023083): Calpains represent a ubiquitous, well-conserved family of calcium-dependent cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large catalytic subunit has four domains: domain I, the N-terminal regulatory domain that is processed upon calpain activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, the calmodulin-like calcium-binding domain. This gene encodes a large subunit. It is an atypical calpain in that it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. It is similar in organization to calpains 5 and 6. This gene is associated with type 2 or non-insulin-dependent diabetes mellitus (NIDDM), and is located within the NIDDM1 region. Multiple alternative transcript variants have been described for this gene. [provided by RefSeq, Sep 2010].
Transcript (Including UTRs)
   Position: hg19 chr2:241,526,133-241,538,526 Size: 12,394 Total Exon Count: 12 Strand: +
Coding Region
   Position: hg19 chr2:241,526,329-241,538,097 Size: 11,769 Coding Exon Count: 12 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsMalaCards
CTDGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein Structure
Other SpeciesGO AnnotationsmRNA DescriptionsPathwaysOther NamesModel Information
Methods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr2:241,526,133-241,538,526)mRNA (may differ from genome)Protein (672 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
H-INVHGNCHPRDLynxMalacardsMGI
neXtProtOMIMPubMedReactomeTreefamUniProtKB
WikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: CAN10_HUMAN
DESCRIPTION: RecName: Full=Calpain-10; EC=3.4.22.-; AltName: Full=Calcium-activated neutral proteinase 10; Short=CANP 10;
FUNCTION: Calcium-regulated non-lysosomal thiol-protease which catalyze limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction.
CATALYTIC ACTIVITY: Broad endopeptidase specificity.
TISSUE SPECIFICITY: Ubiquitous.
DISEASE: Defects in CAPN10 are a cause of susceptibility to diabetes mellitus non-insulin-dependent type 1 (NIDDM1) [MIM:601283]. It is a multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
SIMILARITY: Belongs to the peptidase C2 family.
SIMILARITY: Contains 1 calpain catalytic domain.
SEQUENCE CAUTION: Sequence=BAB47474.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): CAPN10
CDC HuGE Published Literature: CAPN10
Positive Disease Associations: body mass; hemoglobin A(1c) , diabetes, type 2 , diabetes, type 2; insulin; glucose; C-peptide; fatty acid , diabetes, type 2; nephropathy, diabetic , glucose metabolism , hirsutism , hypertension; glucose , insulin resistance; fatty acid , Insulin Resistance|Metabolic Syndrome X|Polycystic Ovary Syndrome , insulin; glucose , insulin; glucose; C-peptide; fatty acid , laryngeal cancer , microvascular function , obesity , polycystic ovarian syndrome , polycystic ovary syndrome , reduced beta(3)-adrenoceptor function , reduced muscle mRNA levels and insulin resistance , triglycerides; obesity
Related Studies:
  1. body mass; hemoglobin A(1c)
    Shima, Y. et al. 2003, Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese., Clinica chimica acta; international journal of clinical chemistry. 2003 Oct;336(2-Jan):89-96. [PubMed 14500039]
    These results indicate the contribution of SNP-19 in CAPN10 to mild obesity and glucose intolerance in Japanese.
  2. diabetes, type 2
    Iwasaki, N. et al. 2005, Genetic variants in the calpain-10 gene and the development of type 2 diabetes in the Japanese population., Journal of human genetics. 2005 ;50(2):92-8. [PubMed 15696376]
    Thus, variation in the calpain-10 gene may affect risk of type 2 diabetes in Japanese, especially in older individuals.
  3. diabetes, type 2
    del Bosque-Plata, L. et al. 2004, Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population., Molecular genetics and metabolism. 2004 Feb;81(2):122-6. [PubMed 14741193]
    The results suggest that variation in CAPN10 affects risk of type 2 diabetes in the mestizo population of central Mexico (Mexico City and Orizaba) and in Mexican Americans (Starr County, Texas).
           more ... click here to view the complete list

-  MalaCards Disease Associations
  MalaCards Gene Search: CAPN10
Diseases sorted by gene-association score: diabetes mellitus, noninsulin-dependent 1* (550), polycystic ovary syndrome (10), diabetes mellitus, noninsulin-dependent (8), muscular dystrophy, limb-girdle, type 2a (6), gestational diabetes (3), obesity (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 18.93 RPKM in Spleen
Total median expression: 436.59 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -108.30196-0.553 Picture PostScript Text
3' UTR -176.90429-0.412 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR022684 - Calpain_cysteine_protease
IPR022682 - Calpain_domain_III
IPR022683 - Calpain_III
IPR000169 - Pept_cys_AS
IPR001300 - Peptidase_C2_calpain_cat

Pfam Domains:
PF00648 - Calpain family cysteine protease
PF01067 - Calpain large subunit, domain III

SCOP Domains:
49758 - Calpain large subunit, middle domain (domain III)
54001 - Cysteine proteinases

ModBase Predicted Comparative 3D Structure on Q9HC96
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologGenome BrowserNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
  Ensembl   
  Protein Sequence   
  Alignment   

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000149 SNARE binding
GO:0004198 calcium-dependent cysteine-type endopeptidase activity
GO:0008092 cytoskeletal protein binding
GO:0008233 peptidase activity
GO:0008234 cysteine-type peptidase activity
GO:0016787 hydrolase activity

Biological Process:
GO:0006508 proteolysis
GO:0006921 cellular component disassembly involved in execution phase of apoptosis
GO:0031532 actin cytoskeleton reorganization
GO:0032024 positive regulation of insulin secretion
GO:0032388 positive regulation of intracellular transport
GO:0032869 cellular response to insulin stimulus
GO:0046326 positive regulation of glucose import
GO:0097050 type B pancreatic cell apoptotic process
GO:2000676 positive regulation of type B pancreatic cell apoptotic process

Cellular Component:
GO:0005622 intracellular
GO:0005739 mitochondrion
GO:0005829 cytosol
GO:0005886 plasma membrane


-  Descriptions from all associated GenBank mRNAs
  AK300279 - Homo sapiens cDNA FLJ61736 complete cds, highly similar to Calpain-10 (EC 3.4.22.-).
AF089088 - Homo sapiens calpain-like protease CAPN10a mRNA, complete cds.
JD135420 - Sequence 116444 from Patent EP1572962.
AK074807 - Homo sapiens cDNA FLJ90326 fis, clone NT2RP2001903, weakly similar to CALPAIN, LARGE [CATALYTIC] SUBUNIT (EC 3.4.22.17).
BC004260 - Homo sapiens calpain 10, mRNA (cDNA clone MGC:10770 IMAGE:3606959), complete cds.
BC007553 - Homo sapiens calpain 10, mRNA (cDNA clone MGC:15475 IMAGE:2967328), complete cds.
AF089095 - Homo sapiens calpain-like protease CAPN10g mRNA, complete cds.
JD214410 - Sequence 195434 from Patent EP1572962.
AB058748 - Homo sapiens KIAA1845 mRNA for KIAA1845 protein.
JD462666 - Sequence 443690 from Patent EP1572962.
JD054734 - Sequence 35758 from Patent EP1572962.
AF089090 - Homo sapiens calpain-like protease CAPN10b mRNA, complete cds.
AF089091 - Homo sapiens calpain-like protease CAPN10c mRNA, complete cds.
AF089092 - Homo sapiens calpain-like protease CAPN10d mRNA, complete cds.
AF089093 - Homo sapiens calpain-like protease CAPN10e mRNA, complete cds.
AF089094 - Homo sapiens calpain-like protease CAPN10f mRNA, complete cds.
AF089096 - Homo sapiens calpain-like protease CAPN10h mRNA, complete cds.
JD395216 - Sequence 376240 from Patent EP1572962.
AB590370 - Synthetic construct DNA, clone: pFN21AE1368, Homo sapiens CAPN10 gene for calpain 10, without stop codon, in Flexi system.
DQ896503 - Synthetic construct Homo sapiens clone IMAGE:100010963; FLH194927.01L; RZPDo839G0770D calpain 10 (CAPN10) gene, encodes complete protein.
DQ893519 - Synthetic construct clone IMAGE:100006149; FLH194931.01X; RZPDo839G0780D calpain 10 (CAPN10) gene, encodes complete protein.
BC107088 - Homo sapiens cDNA clone IMAGE:40014500.
AK128552 - Homo sapiens cDNA FLJ46711 fis, clone TRACH3016455, highly similar to Homo sapiens calpain 10 (CAPN10).
AK027330 - Homo sapiens cDNA FLJ14424 fis, clone HEMBA1005815, weakly similar to CALPAIN, LARGE [CATALYTIC] SUBUNIT (EC 3.4.22.17).
JD446153 - Sequence 427177 from Patent EP1572962.
JD518334 - Sequence 499358 from Patent EP1572962.
JD372569 - Sequence 353593 from Patent EP1572962.
JD222590 - Sequence 203614 from Patent EP1572962.
JD479930 - Sequence 460954 from Patent EP1572962.
JD537211 - Sequence 518235 from Patent EP1572962.
JD340273 - Sequence 321297 from Patent EP1572962.
JD094499 - Sequence 75523 from Patent EP1572962.
JD538262 - Sequence 519286 from Patent EP1572962.
JD228242 - Sequence 209266 from Patent EP1572962.
JD447813 - Sequence 428837 from Patent EP1572962.
JD107886 - Sequence 88910 from Patent EP1572962.
JD141493 - Sequence 122517 from Patent EP1572962.
JD453032 - Sequence 434056 from Patent EP1572962.
JD408425 - Sequence 389449 from Patent EP1572962.
JD155710 - Sequence 136734 from Patent EP1572962.
JD446486 - Sequence 427510 from Patent EP1572962.
JD322859 - Sequence 303883 from Patent EP1572962.
JD203352 - Sequence 184376 from Patent EP1572962.
JD468347 - Sequence 449371 from Patent EP1572962.
JD152536 - Sequence 133560 from Patent EP1572962.
JD518639 - Sequence 499663 from Patent EP1572962.
JD382634 - Sequence 363658 from Patent EP1572962.
JD339824 - Sequence 320848 from Patent EP1572962.
JD338822 - Sequence 319846 from Patent EP1572962.
JD479893 - Sequence 460917 from Patent EP1572962.
JD049818 - Sequence 30842 from Patent EP1572962.
JD287198 - Sequence 268222 from Patent EP1572962.
JD493008 - Sequence 474032 from Patent EP1572962.
JD448920 - Sequence 429944 from Patent EP1572962.
JD216888 - Sequence 197912 from Patent EP1572962.
JD477346 - Sequence 458370 from Patent EP1572962.
JD477347 - Sequence 458371 from Patent EP1572962.
JD514829 - Sequence 495853 from Patent EP1572962.
JD442092 - Sequence 423116 from Patent EP1572962.
JD420814 - Sequence 401838 from Patent EP1572962.
JD206867 - Sequence 187891 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q9HC96 (Reactome details) participates in the following event(s):

R-HSA-8848658 CAPN:4xCa2+:CAPNS cleave cytoskeletal proteins
R-HSA-1474228 Degradation of the extracellular matrix
R-HSA-1474244 Extracellular matrix organization

-  Other Names for This Gene
  Alternate Gene Symbols: A8MVS7, CAN10_HUMAN, KIAA1845, NM_023083, NP_075571, Q4ZFV1, Q8NCD4, Q96IG4, Q96JI2, Q9HC89, Q9HC90, Q9HC91, Q9HC92, Q9HC93, Q9HC94, Q9HC95, Q9HC96
UCSC ID: uc002vzk.2
RefSeq Accession: NM_023083
Protein: Q9HC96 (aka CAN10_HUMAN or CANA_HUMAN)
CCDS: CCDS42838.1

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_023083.3
exon count: 12CDS single in 3' UTR: no RNA size: 2662
ORF size: 2019CDS single in intron: no Alignment % ID: 99.96
txCdsPredict score: 4204.00frame shift in genome: no % Coverage: 99.32
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.